RESUMO
Augmentation mammaplasty continues to attract much attention. So far, it seems to be an operation with an indefinite endpoint regarding the longevity of results. It is also a procedure that has wide monetary implications and would often seem to be inappropriately used. With the advent of the latest polyurethane-covered prostheses, marketed under various trade names such as Meme, Replicon, and Optimam, a more predictable result can be obtained, at least for the first 6 years. Much controversy still exists, and in view of this, the authors have revised their long-term results and comments on important current aspects.
Assuntos
Mama , Mamoplastia , Próteses e Implantes , Mama/cirurgia , Neoplasias da Mama/etiologia , Feminino , Seguimentos , História do Século XX , Humanos , Mamoplastia/efeitos adversos , Mamoplastia/história , Mamoplastia/instrumentação , PoliuretanosRESUMO
One of the advantages of polyurethane foam-covered prostheses has been that in the first 5 to 10 years after their use, the amount of capsular contraction was found much less than when similar "slick" prostheses were used. Another advance was their fixation to the surrounding tissue thus giving a more natural appearance and movement with the muscles when the arms were moved in any direction. The formation of a thick capsule also acted as a protection against gel granuloma due to rupture of the prosthesis and has been thought to be a factor in the lower capsule contraction rate. The greatest disadvantage has been that its removal was extremely difficult and this has continued up until the technique described in this paper has been introduced.
Assuntos
Implantes de Mama , Géis , Humanos , Poliuretanos , Desenho de Prótese , ReoperaçãoRESUMO
Long-term reviews of patients undergoing augmentation mammaplasty seem to be rare. Recently, a long-term study of patients who had undergone augmentation with polyurethane foam-covered prostheses was undertaken. However, at the time that study was published, the longest follow-up was just over 4 years. We have been using the polyurethane-coated prosthesis almost exclusively for nearly 20 years. The procedure is performed by one surgeon using a consistent technique, and all implantations were retroglandular. In reviewing this series, a follow-up rate of nearly 60% was achieved in patients augmented for periods of 1 to 19 years. The length of this study, together with a high follow-up compliance rate, makes this an unusual contribution to the literature on augmentation mammaplasty.